Evidence map›Paper›PMID 31324153›Full record

ArticleBMC neurology2019

Myasthenic crisis treated in a Chinese neurological intensive care unit: clinical features, mortality, outcomes, and predictors of survival.

Fan Liu, Qiong Wang, Xueping Chen

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mortality of myasthenia gravis: a national population-based study in China.Annals of clinical and translational neurology · 2023
    Article
  8. Review
  9. Nomogram for the acute exacerbation of acetylcholine receptor antibody-positive generalized myasthenia gravis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  10. Article
  11. Myasthenia gravis treated in the neurology intensive care unit: a 14-year single-centre experience.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Fan LiuDepartment of Nursing, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
Qiong WangNeurological Intensive Care Unit, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xueping ChenDepartment of Neurology, West China Hospital, Sichuan University, 610041, Guoxuexiang #37, Chengdu, Sichuan, China. chenxueping0606@sina.com.ORCID http://orcid.org/0000-0003-4290-7404
Sichuan University · CN

Funding

National Natural Science Foundation of China 81301093
6 · The paper itself

Abstract

backgroundMyasthenic crisis (MC) often requires admission to an intensive care unit (ICU).

methodsWe retrospectively investigated 113 consecutive patients with first MC admitted to the neurological ICU. Patients' demographic, clinical and other characteristics were examined, as well as therapeutic interventions, mortality and functional outcome.

resultsMC patients at first onset admitted to neurological ICU had a mortality rate of 18.6%. PCO

conclusionsOur results suggest that PCO

Indexed as

AdultAgedAsian PeopleFemaleHumansIntensive Care UnitsMaleMiddle AgedMyasthenia GravisRetrospective StudiesTreatment OutcomeClinical characteristicsIntensive care unitManagementMyasthenic crisisOutcomesSurvival predictor

Identifiers

PMID31324153
PMCPMC6642475
OpenAlexW2962943362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.